Oncology

Lynparza is a first in class PARP inhibitor for the monotherapy treatment of patients with metastatic castration resistant prostate cancer.

Adcetris is currently the only approved molecular-targeted therapy for Hodgkins lymphoma.

NFL Hall of Famer and Super Bowl champion Mike Haynes seeks to spread awareness about prostate cancer following his fight with the disease.

Handheld miniature microscope allows surgeons to see cancer at a cellular level.

Younger melanoma patients undergo indoor tanning more frequently than older women with melanoma.

Abraxane and gemcitabine evaluated in first-line patients with metastatic pancreatic cancer.

Abraxane and gemcitabine evaluated in first-line patients with metastatic pancreatic cancer.

Inherited genetic markers in immune response pathways associated with melanoma survival.

Sirolimus shows promise in decreasing skin cancer risk among organ transplant patients.

The expanded use of Opdivo and Yervoy includes patients with BRAF V600 wild-type mutation-positive unresectable or metastatic melanoma.

New method may offer safer alternative to target tumors and minimize awful side effects for cancer patients.

Researchers find mechanism that enables cells to migrate in a specific tissue.

Researchers find cancer evolves in specific patterns that are predictable through the laws of nature.

Genetic modifications enhance local DNA repair and protection in cancer treatment.

Aggressive surgery to remove all cancer cells followed by targeted chemotherapy shows potential to significantly improve ovarian cancer survival.

Top news of the week in cancer drug development and research.

Tumors that over-express a specific oncogene may benefit from combination therapy regardless of cancer type.

New research may transform oncology drug development.

Researchers warn political interference may discourage shared decision-making in breast cancer treatment.

Use of exomes shield lung cancer drug from immune system defenses.

Researchers examine use of docetaxel in patients with castration-resistant metastatic prostate cancer following androgen-deprivation therapy.

Byproduct found in cotton plant rid the body of abnormal cancerous cells.

Researchers examine use of docetaxel in patients with castration-resistant metastatic prostate cancer following androgen-deprivation therapy.

Use of exomes shield lung cancer drug from immune system defenses.

Researchers examine how genetic changes in breast cancer cells interfere with pathways critical to disease growth and survival.

Breakthrough cancer pain can be difficult for providers to measure.

Metformin decreased inflammation and scarring observed in more common pancreatic cancers.

Combination of diclofenac with chemotherapy and radiation may greatly improve treatment of cancer patients.